Screener
AbCellera Biologics Inc. ABCL Research fees — Total Revenue
Other product segments
Similar metrics at other companies
Other financials
Where this comes from
Reported directly by AbCellera Biologics Inc. in its filing.
Tagged under the XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax.
The source filing: AbCellera Biologics Inc.’s 10-Q, filed August 5, 2026.
- Filed
- Aug 5, 2026, 4:28 PM EDT
- Fiscal quarter
- Q2 FY2026
- Calendar quarter
- Q2 2026
- Accession
- 0001703057-26-000046
| Line item | Three months ended June 30, 2025 | Three months ended June 30, 2026 | Six months ended June 30, 2025 | Six months ended June 30, 2026 |
|---|---|---|---|---|
| Revenue: | ||||
| Research fees | $6,639 | $3,901 | $10,707 | $12,021 |
| Licensing and royalty revenue | 10,445 | 149 | 10,613 | 341 |
| Total revenue | 17,084 | 4,050 | 21,320 | 12,362 |
| Operating expenses: | ||||
| Research and development(1) | 39,213 | 45,987 | 81,711 | 92,649 |
| Sales, general, and administrative(1) | 21,986 | 13,850 | 41,054 | 26,185 |
| Depreciation and amortization | 5,470 | 6,990 | 10,801 | 13,828 |
Item 1. Financial Statements (Unaudited)
FAQ
- What is AbCellera Biologics Inc.'s research fees — total revenue?
- AbCellera Biologics Inc. (ABCL) reported research fees — total revenue of $3.9M in Q2 2026.
- How has AbCellera Biologics Inc.'s research fees — total revenue changed year-over-year?
- AbCellera Biologics Inc.'s research fees — total revenue decreased by 41.2% year-over-year, from $6.64M to $3.9M.
- What is the long-term trend for AbCellera Biologics Inc.'s research fees — total revenue?
- Over 4 years (2021 to 2025), AbCellera Biologics Inc.'s research fees — total revenue has grown at a 9.3% compound annual growth rate (CAGR), from $19.08M to $27.21M.
- What does research fees — total revenue mean?
- This metric represents the total revenue generated from research and development service fees charged to partners for antibody discovery projects. It reflects the company's ability to monetize its proprietary technology platform through upfront payments and service-based engagements before clinical milestones are reached. Tracking this revenue stream provides insight into the demand for the company's early-stage discovery services and the health of its collaborative pipeline.
Ask your AI about AbCellera Biologics Inc.'s research fees — total revenue.
Connect your AI assistant and compare segments, right in your chat.
Connect your AI
Claude